Recent insider trading activity from Ballantyne Charles Evan, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 10, 2023 | Gain Therapeutics, Inc. | $GANX | Ballantyne Charles Evan | Chief Financial Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 11,935,081 | 9999.99% | 0.84% |
| April 10, 2023 | Gain Therapeutics, Inc. | $GANX | Ballantyne Charles Evan | Chief Financial Officer | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 11,935,081 | 9999.99% | 0.42% |